The present invention provides compounds useful for increasing cellular ATP binding cassette transporter ABCA1 production in mammals, and to methods of using such compounds in the treatment of coronary artery diseases, dyslipidiemias and metabolic syndrome. The invention also relates to methods for the preparation of such compounds, and to pharmaceutical compositions containing them.
The present invention provides compounds useful for increasing cellular ATP binding cassette transporter ABCA1 production in mammals, and to methods of using such compounds in the treatment of coronary artery diseases, dyslipidiemias and metabolic syndrome. The invention also relates to methods for the preparation of such compounds, and to pharmaceutical compositions containing them.
[EN] ABCA1 ELEVATING COMPOUNDS<br/>[FR] COMPOSÉS AUGMENTANT LE TAUX EN ABCA1
申请人:CV THERAPEUTICS INC
公开号:WO2007002867A1
公开(公告)日:2007-01-04
[EN] The present invention provides compounds useful for increasing cellular ATP binding cassette transporter ABCAl production in mammals, and to methods of using such compounds in the treatment of coronary artery diseases, dyslipidiemias and metabolic syndrome. The invention also relates to methods for the preparation of such compounds, and to pharmaceutical compositions containing them. [FR] La présente invention concerne des composés pouvant être employés pour augmenter la production du transporteur ABCA1 (ATP-Binding-Cassette A1) chez les mammifères, ainsi que des méthodes d'emploi de tels composés dans le traitement de maladies coronariennes, de dyslipidémies et du syndrome métabolique. La présente invention concerne également des méthodes de synthèse de tels composés et des préparations pharmaceutiques les contenant.